Sign in

CIK 0001087294

  • Non-accelerated filer
  • Smaller reporting company

CUMBERLAND PHARMACEUTICALS INC

Sign in to watch
Ticker
CPIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
TN
Entity type
Operating
EIN
621765329
Phone
+1 615-255-0068
Business address
1600 WEST END AVENUE, SUITE 1300, NASHVILLE,, TN, 37203
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-03-18 Hamm John M. VP Chief Financial Officer Grant or award · Options (right to buy) +3,000 $2.80 $8K 18,250
2025-03-17 Hamm John M. VP Chief Financial Officer Grant or award · Options (right to buy) +2,750 $5.17 $14K 15,250
2025-03-16 Hamm John M. VP Chief Financial Officer Shares withheld for taxes −5,930 $5.46 $32K 20,073
2024-03-25 Hamm John M. VP Chief Financial Officer Grant or award · Options (right to buy) +5,500 $1.71 $9K 12,500
2024-03-23 Hamm John M. VP Chief Financial Officer Shares withheld for taxes −445 $1.81 $805 26,003
2023-11-27 Hamm John M. Chief Financial Officer Shares withheld for taxes −352 $1.67 $588 26,448
2023-03-24 Hamm John M. Chief Financial Officer Grant or award · Options (right to buy) +2,000 7,000
2022-03-16 Hamm John M. Chief Financial Officer Grant or award +20,000 $2.59 $52K 26,800
2022-03-16 Hamm John M. Chief Financial Officer Grant or award · Options (right to buy) +2,000 2,000
2021-11-23 Hamm John M. Chief Financial Officer Purchase +3,800 $2.35 $9K 6,800

Page 1 of 1 · 10 trades